Publicaciones (77) Publicaciones en las que ha participado algún/a investigador/a

2018

  1. A diphenyldiselenide derivative induces autophagy via JNK in HTB-54 lung cancer cells

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 1, pp. 289-301

  2. A systems pharmacology model for inflammatory bowel disease

    PLoS ONE, Vol. 13, Núm. 3

  3. Activity enhancement of selective antitumoral selenodiazoles formulated with poloxamine micelles

    Colloids and Surfaces B: Biointerfaces, Vol. 170, pp. 463-469

  4. Adrenomedullin, a Novel Target for Neurodegenerative Diseases

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 8799-8814

  5. Advances in parkinson’s disease: 200 years later

    Frontiers in Neuroanatomy, Vol. 12

  6. Analysis of mycotoxins in peruvian evaporated cow milk

    Beverages, Vol. 4, Núm. 2

  7. Bioaccessibility and biological activity of Melissa officinalis, Lavandula latifolia and Origanum vulgare extracts: Influence of an in vitro gastrointestinal digestion

    Journal of Functional Foods, Vol. 44, pp. 146-154

  8. Bioavailability of two oral fentanyl transmucosal formulations in healthy volunteers: An open-label, crossover, randomised study

    Revista de la Sociedad Espanola del Dolor, Vol. 25, Núm. 4, pp. 222-227

  9. Biocompatible porous metal-organic framework nanoparticles based on Fe or Zr for gentamicin vectorization

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 132, pp. 11-18

  10. Chemo- and Regioselective Lysine Modification on Native Proteins

    Journal of the American Chemical Society, Vol. 140, Núm. 11, pp. 4004-4017

  11. Coencapsulation of cyclodextrins into poly(anhydride) nanoparticles to improve the oral administration of glibenclamide. A screening on C. elegans

    Colloids and Surfaces B: Biointerfaces, Vol. 163, pp. 64-72

  12. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions

    Journal of Dermatological Science, Vol. 92, Núm. 1, pp. 78-88

  13. Combined Acylselenourea-Diselenide Structures: New Potent and Selective Antitumoral Agents as Autophagy Activators

    ACS Medicinal Chemistry Letters, Vol. 9, Núm. 4, pp. 306-311

  14. Computer simulations for bioequivalence trials: Selection of analyte in BCS class II and IV drugs with first-pass metabolism, two metabolic pathways and intestinal efflux transporter

    European Journal of Pharmaceutical Sciences, Vol. 117, pp. 193-203

  15. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

  16. Cyclodextrin-grafted poly(anhydride) nanoparticles for oral glibenclamide administration. In vivo evaluation using C. elegans

    International Journal of Pharmaceutics, Vol. 547, Núm. 1-2, pp. 97-105

  17. Cytotoxic activity of fucoxanthin, alone and in combination with the cancer drugs imatinib and doxorubicin, in CML cell lines

    Environmental Toxicology and Pharmacology, Vol. 59, pp. 24-33

  18. Disminución de los niveles de serotonina tras una intervención de estilo de vida en niños obesos: Asociación con glucosa y medidas antropométricas

    Nutricion Hospitalaria, Vol. 35, Núm. 2, pp. 279-285

  19. Drug resistance in glioblastoma and cytotoxicity of seaweed compounds, alone and in combination with anticancer drugs: A mini review

    Phytomedicine, Vol. 48, pp. 84-93

  20. Enhanced Permeability and Binding Activity of Isobutylene-Grafted Peptides

    Chembiochem : a European journal of chemical biology, Vol. 19, Núm. 1, pp. 48-52